DRD2 and hyperprolactinemia: Data obtained with lymphoblastoid cell lines suggested that -241G carriers have higher DRD2 expression levels than non-carriers (Nyman et al., 2009), which is consistent with our conclusion that DRD2 -241A>G is involved in hyperprolactinemia.